Women of childbearing potential must be willing to abstain from heterosexual activity or use an effective method of contraception from the time of informed consent until  weeks after treatment discontinuation
PHASE I: Sexually active male subjects must use an effective method of contraception (barrier method of birth control or abstinence) from the time of consent until at least  days following discontinuation of protocol therapy
PHASE IB: Sexually active male subjects must use an effective method of contraception (barrier method of birth control or abstinence) from the time of consent until at least  days following discontinuation of protocol therapy
Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks after treatment discontinuation
Females of childbearing potential must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks after treatment discontinuation. Subject's partner must also use barrier protection while subject is on study until  weeks after treatment discontinuation.
Males must be willing to use an effective method of contraception/method to avoid seminal transfer (barrier method or abstinence) from the time consent is signed until  weeks after treatment discontinuation. Subject's partner must also use barrier protection while subject is on study until  weeks after treatment discontinuation.
Females and males of childbearing potential must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks (for males) and  months (for females) after treatment discontinuation
Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks after treatment discontinuation
Women of childbearing potential and males must be willing to use an effective method of contraception from the time consent is signed until  weeks after treatment discontinuation
Women of childbearing potential must be willing to abstain from heterosexual activity or use an effective method of contraception from the time of informed consent until  months after treatment discontinuation. Women cannot breast feed from the time of informed consent to  months after last dose of study treatment.
All subjects, including those who are surgically sterilized, must be willing to use an effective method of contraception (barrier method of birth control or abstinence) from the time informed consent is signed until  months after completion of protocol therapy
All subjects, including those who are surgically sterilized, must be willing to use an effective method of contraception (barrier method of birth control or abstinence) from the time informed consent is signed until  months after completion of protocol therapy.
Women of childbearing potential and males must be willing to use an effective method of contraception from the time consent is signed until  weeks after treatment discontinuation.
Women and men of childbearing potential must be willing to use an effective method of contraception (e.g. hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks after protocol therapy discontinuation.
Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal, barrier method of birth control or abstinence) from the time the consent is signed, during the duration of study participation and  months after discontinuation of protocol therapy
Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until  weeks after treatment discontinuation.